Modification of the association between lead exposure and amyotrophic lateral sclerosis by iron and oxidative stress related gene polymorphisms

References

• Barber SC, Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med. 2010;48:629–41.
   PubMed Web of Science ®Google Scholar
• Johnson FO, Atchison WD. The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology. 2009;30: 761–5.
   PubMed Web of Science ®Google Scholar
• Sutedja NA, Veldink JH, Fischer K, Kromhout H, Heederik D, Huisman MH, et al. Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler. 2009;10:302–9.
   PubMed Web of Science ®Google Scholar
• Factor-Litvak P, Al-Chalabi A, Ascherio A, Bradley W, Chio A, Garruto R, et al. Current pathways for epidemiological research in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14 (Suppl 1): 33–43.
   PubMed Web of Science ®Google Scholar
• Kamel F, Umbach DM, Munsat TL, Shefner JM, Hu H, Sandler DP. Lead exposure and amyotrophic lateral sclerosis. Epidemiology. 2002;13:311–9.
   PubMed Web of Science ®Google Scholar
• Fang F, Kwee LC, Allen KD, Umbach DM, Ye W, Watson M, et al. Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol. 2010; 171:1126–33.
   PubMed Web of Science ®Google Scholar
• Vonk WI, Klomp LW. Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis. Biochem Soc Trans. 2008;36:1322–8.
   PubMed Web of Science ®Google Scholar
• Feder JN. The hereditary hemochromatosis gene (HFE): a MHC class I-like gene that functions in the regulation of iron homeostasis. Immunol Res. 1999;20:175–85.
   Google Scholar
• Hall EC, Lee SY, Mairuae N, Simmons Z, Connor JR. Expression of the HFE allelic variant H63D in SH-SY5Y cells affects tau phosphorylation at serine residues. Neurobiol Aging. 2011;32:1409–19.
   Google Scholar
• Lee SY, Patton SM, Henderson RJ, Connor JR. Consequences of expressing mutants of the hemochromatosis gene (HFE) into a human neuronal cell line lacking endogenous HFE. FASEB J. 2007;21:564–76.
   Google Scholar
• Namekata K, Oyama F, Imagawa M, Ihara Y. Human transferrin (Tf): a single mutation at codon 570 determines Tf C1 or Tf C2 variant. Hum Genet. 1997;100:457–8.
   Google Scholar
• Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154–66.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci. 1994;124 (Suppl): 96–107.
   PubMed Web of Science ®Google Scholar
• Weisskopf MG, Weuve J, Nie H, Saint-Hilaire MH, Sudarsky L, Simon DK, et al. Association of cumulative lead exposure with Parkinson’s disease. Environ Health Perspect. 2010;118:1609–13.
   PubMed Web of Science ®Google Scholar
• Aro A, Amarasiriwardena C, Lee ML, Kim R, Hu H. Validation of K-X-ray fluorescence bone lead measurements by inductively coupled plasma mass spectrometry in cadaver legs. Med Phys. 2000;27:119–23.
   PubMed Web of Science ®Google Scholar
• Aro AC, Todd AC, Amarasiriwardena C, Hu H. Improvements in the calibration of 109Cd K-X-ray fluorescence systems for measuring bone lead in vivo. Phys Med Biol. 1994;39:2263–71.
   Google Scholar
• Nie H, Hu H, Chettle DR. Application and methodology of in vivo K-X-ray fluorescence of Pb in bone (impact of KXRF data in the epidemiology of lead toxicity, and consistency of the data generated by updated systems) X-Ray Spectrometry Volume 37, Issue 1. X-Ray Spectrometry. 2008;37:69–75.
   Google Scholar
• Wilker E, Korrick S, Nie LH, Sparrow D, Vokonas P, Coull B, et al. Longitudinal changes in bone lead levels: the VA Normative Aging Study. J Occup Environ Med. 2011; 53:850–5.
   PubMed Web of Science ®Google Scholar
• Kim R, Landrigan C, Mossmann P, Sparrow D, Hu H. Age and secular trends in bone lead levels in middle-aged and elderly males: three-year longitudinal follow-up in the Normative Aging Study. Am J Epidemiol. 1997;146: 586–91.
   PubMed Web of Science ®Google Scholar
• Kleinbaum DG, Klein M. Logistic regression: a self-learning text: Springer; 2010.
   Google Scholar
• Morimoto LM, White E, Newcomb PA. Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol. 2003;158:259–63.
   PubMed Web of Science ®Google Scholar
• Wacholder S, Chatterjee N, Hartge P. Joint effect of genes and environment distorted by selection biases: implications for hospital based case-control studies. Cancer Epidemiol Biomarkers Prev. 2002;11:885–9.
   Google Scholar
• Vanderweele TJ, Mukherjee B, Chen J. Sensitivity analysis for interactions under unmeasured confounding. Stat Med. 2012;31:2552–64.
   Web of Science ®Google Scholar
• Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43–6.
   PubMedGoogle Scholar
• Goldberg M, Silbergeld E. On multiple comparisons and on the design and interpretation of epidemiological studies of many associations. Environ Res. 2011;111:1007–9.
   PubMed Web of Science ®Google Scholar
• Yen AA, Simpson EP, Henkel JS, Beers DR, Appel SH. HFE mutations are not strongly associated with sporadic ALS. Neurology. 2004;62:1611–2.
   PubMed Web of Science ®Google Scholar
• Sutedja NA, Sinke RJ, van Vught PW, van der Linden MW, Wokke JH, van Duijn CM, et al. The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population. Archives of Neurology. 2007; 64:63–7.
   PubMedGoogle Scholar
• Goodall EF, Greenway MJ, van Marion I, Carroll CB, Hardiman O, Morrison KE. Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS. Neurology. 2005;65:934–7.
   PubMed Web of Science ®Google Scholar
• Restagno G, Lombardo F, Ghiglione P, Calvo A, Cocco E, Sbaiz L, et al. HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin. J Neurol Neurosurg Psychiatry. 2007;78:327.
   Google Scholar
• He X, Lu X, Hu J, Xi J, Zhou D, Shang H, et al. H63D polymorphism in the hemochromatosis gene is associated with sporadic amyotrophic lateral sclerosis in China. European Journal of Neurology : the official journal of the European Federation of Neurological Societies. 2011;18: 359–61.
   PubMed Web of Science ®Google Scholar
• Praline J, Blasco H, Vourc’h P, Rat V, Gendrot C, Camu W, et al. Study of the HFE gene common polymorphisms in French patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci. 2012;317:58–61.
   PubMed Web of Science ®Google Scholar
• van Rheenen W, Diekstra FP, van Doormaal PT, Seelen M, Kenna K, McLaughlin R, et al. H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis. Neurobiol Aging. 2013;34:1517.
   Google Scholar
• Mitchell RM, Lee SY, Simmons Z, Connor JR. HFE polymorphisms affect cellular glutamate regulation. Neurobiol Aging. 2011;32:1114–23.
   Google Scholar
• Mitchell RM, Lee SY, Randazzo WT, Simmons Z, Connor JR. Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1. J Neuroinflammation. 2009;6:6.
   Google Scholar
• Nandar W, Connor JR. HFE gene variants affect iron in the brain. The Journal of Nutrition. 2011;141:S729–39.
   PubMed Web of Science ®Google Scholar
• Onalaja AO, Claudio L. Genetic susceptibility to lead poisoning. Environ Health Perspect. 2000;108 (Suppl 1):23–8.
   PubMed Web of Science ®Google Scholar